Skip to main content

Table 6 Multivariate analysis of OS on pretreatment quality of life of QLQ-C30 among 501 patients with nasopharyngeal carcinoma

From: Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

  HR 95%CI P
Age 1.329 0.516–3.427 0.556
Gender 0.493 0.136–1.795 0.284
Marriage 1.524 0.226–10.298 0.665
Education 1.145 0.763–1.720 0.513
Smoking history 1.246 0.483–3.216 0.650
Alcohol history 0.268 0.034–2.125 0.213
T stage 2.353 0.539–10.275 0.255
N stage 1.675 0.686–4.090 0.257
Pre-treatment EBV DNA 0.816 0.342–1.946 0.646
Post-treatment EBV DNA 11.202 1.473–85.184 0.020
Pain 1.028 0.996–1.061 0.091
Swallowing 1.014 0.978–1.050 0.458
  1. Abbreviations: OS Overall sruvival, HR Harsard ratio
\